Oncology & Cancer

'Dramatic' early phase 1 results for AG-120 in IDH1 mutated AML

Results presented November 19 by University of Colorado Cancer Center investigator Daniel Pollyea, MD, MS, at the 26th European Organisation for Research and Treatment of Cancer Symposium in Barcelona show "extremely promising" ...

Oncology & Cancer

Variation in proportion of cancer survivors undergoing HIV testing

(HealthDay)—The proportion of cancer survivors undergoing HIV testing varies by state and demographic and health-related factors, according to a study published Nov. 13 in the U.S. Centers for Disease Control and Prevention's ...

page 31 from 40